DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Torrent Pharmaceuticals Limited (TORNTPHARM) share price today?

Torrent Pharmaceuticals Limited (TORNTPHARM) is trading at ₹4,558.9 on the NSE, down 0.55% on the day. Source: DocStoX.

What is the PE ratio of Torrent Pharmaceuticals Limited?

Torrent Pharmaceuticals Limited has a price-to-earnings (PE) ratio of 71.3 in the Healthcare sector.

What is the market capitalisation of Torrent Pharmaceuticals Limited?

Torrent Pharmaceuticals Limited has a market capitalisation of approximately ₹1.73 lakh crore.

Is Torrent Pharmaceuticals Limited a profitable company?

Torrent Pharmaceuticals Limited generates a return on equity of 25.8% with a net profit margin of 15.3%. That is a strong return on shareholder capital.

What is the 52-week high and low of TORNTPHARM?

Torrent Pharmaceuticals Limited (TORNTPHARM) has traded between ₹3,505.5 and ₹5,250 over the past 52 weeks, against a current price of ₹4,558.9.

Does Torrent Pharmaceuticals Limited pay a dividend?

Yes. Torrent Pharmaceuticals Limited currently offers a dividend yield of 0.77%. Dividend payments depend on the board's declaration each year.

Torrent Pharmaceuticals Limited

F&O

₹4,558.90▼ -25.20 (-0.55%)

TORNTPHARM·NSE·Healthcare

Market Cap

173441.54 Cr

PE Ratio

71.32

Volume

2,11,025

Day High - Low

4618.90 - 4550.40

52W High-Low

5250.00 - 3505.50

₹4,558.90▼ -25.20 (-0.55%)

Market Cap173441.54 Cr

PE Ratio71.32

Volume2,11,025

Day High - Low4618.90 - 4550.40

52W High-Low5250.00 - 3505.50

Torrent Pharmaceuticals Limited (TORNTPHARM): company summary

The company's business is growing, with annual revenue rising 21.4% and annual net profit increasing 11.9%.

Torrent Pharmaceuticals Limited (TORNTPHARM) is a large-cap Healthcare company valued at ₹1.73 lakh crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Torrent Pharmaceuticals Limited last traded at ₹4,558.9, modestly down 0.55% on the day.
Recent developments: On 2026-07-30, Torrent Pharmaceuticals reported a 3% rise in profit to ₹566 crore for the first quarter, with revenue surging to ₹4,921 crore, driven by strong performance in India.
Financial performance: The company's business is growing, with annual revenue rising 21.4% and annual net profit increasing 11.9%. The latest quarter saw revenue jump 54.8% compared to the same quarter a year earlier, while net profit rose 3.3%.
Valuation multiples: The stock trades at 71.3 times earnings, a premium to the Healthcare median of 32.0, 22.29 times book value. It yields 0.8%.
Things to watch: The company's net profit margin has declined 1.3 percentage points to 15.3%, and its debt to equity ratio stands at 1.79, indicating higher leverage. The stock is 13.2% below its 52-week high.
Where it stands: Torrent Pharmaceuticals has delivered strong revenue growth, with the latest quarter showing a significant increase. However, the net profit margin has narrowed, and the stock is trading below its recent peak. The debt to equity ratio remains a key factor to note.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.4/10

Weak

Fair Value

ROE

25.78%

Strong

P/E

71.32x

Expensive

Debt / Equity

1.79

High

Industry

Healthcare

Pharmaceuticals

Overall View

Weak

Price performance

NIFTY NEXT 50NIFTY 100NIFTY 200

Day₹4550

₹4619

52W₹3506

₹5250

DocStoX take

Supported by quality (7.4) and risk (7.4), but held back by valuation (0.0).

DocStoX score

Low confidence

5.4

/10

Weak

Quality

Solid

ROE 25.8%

Valuation

Expensive

P/E 71.3×

Growth

Steady

Revenue +11.8% 5Y CAGR

Risk

Moderate

D/E 1.79

Momentum

Firm

60% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹4,559

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹1.73L Cr

52W High / Low

₹5250 / ₹3506

Dividend Yield

0.77%

Promoter Holding

60.78%

EPS (TTM)

₹63.92

Book Value

₹247.86

Key highlights

Profitable in all of the last 5 years
Strong returns on equity (26%)
Healthy net margin (15%)
High leverage — debt is 1.8× equity
Valuation is weak (0.0/10)

3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Torrent Pharmaceuticals Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Torrent Pharmaceuticals Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited Max Healthcare Institute Limited

Compare Torrent Pharmaceuticals Limited with peers

Torrent Pharmaceuticals Limited vs Sun Pharmaceutical Industries Limited Torrent Pharmaceuticals Limited vs Divi's Laboratories Limited Torrent Pharmaceuticals Limited vs Apollo Hospitals Enterprise Limited Torrent Pharmaceuticals Limited vs Zydus Lifesciences Limited Torrent Pharmaceuticals Limited vs Laurus Labs Limited Torrent Pharmaceuticals Limited vs Cipla Limited

Related tools & concepts

Value Torrent Pharmaceuticals Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

TORNTPHARM newsLatest coverage & filings Open screenerFilter the whole market